申请人:Oballa Renata
公开号:US20090291988A1
公开(公告)日:2009-11-26
The instant invention relates to compounds of formula I, diagrammed below, wherein R3, E, D and Y are defined in the application, which are useful as reversible inhibitors of monoamine oxidase-B and/or monoamine oxidase-A, and therefore useful to treat or prevent neurological diseases or conditions in mammals, preferably humans.
本发明涉及公式I所示的化合物,其中R3、E、D和Y在申请中有定义,这些化合物可用作可逆的单胺氧化酶B和/或单胺氧化酶A的抑制剂,因此可用于治疗或预防哺乳动物(特别是人类)的神经疾病或症状。